Logo image of INVX

INNOVEX INTERNATIONAL INC (INVX) Stock Fundamental Analysis

NYSE:INVX - New York Stock Exchange, Inc. - US4576511079 - Common Stock - Currency: USD

15.91  +0.64 (+4.19%)

After market: 15.91 0 (0%)

Fundamental Rating

6

We assign a fundamental rating of 6 out of 10 to INVX. INVX was compared to 62 industry peers in the Energy Equipment & Services industry. While INVX has a great health rating, its profitability is only average at the moment. INVX is showing excellent growth while it is valued at reasonable prices. Keep and eye on this one! With these ratings, INVX could be worth investigating further for growth investing!.


Dividend Valuation Growth Profitability Health

6

1. Profitability

1.1 Basic Checks

INVX had negative earnings in the past year.
In the past year INVX had a positive cash flow from operations.
The reported net income has been mixed in the past 5 years: INVX reported negative net income in multiple years.
In multiple years INVX reported negative operating cash flow during the last 5 years.
INVX Yearly Net Income VS EBIT VS OCF VS FCFINVX Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M -100M 200M

1.2 Ratios

INVX has a Return On Assets of 10.05%. This is amongst the best in the industry. INVX outperforms 85.48% of its industry peers.
The Return On Equity of INVX (12.56%) is better than 67.74% of its industry peers.
INVX has a Return On Invested Capital (6.88%) which is comparable to the rest of the industry.
Industry RankSector Rank
ROA 10.05%
ROE 12.56%
ROIC 6.88%
ROA(3y)3.87%
ROA(5y)-0.76%
ROE(3y)4.84%
ROE(5y)-0.55%
ROIC(3y)N/A
ROIC(5y)N/A
INVX Yearly ROA, ROE, ROICINVX Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5 -5 10 -10

1.3 Margins

Looking at the Profit Margin, with a value of 15.61%, INVX belongs to the top of the industry, outperforming 87.10% of the companies in the same industry.
In the last couple of years the Profit Margin of INVX has grown nicely.
INVX's Operating Margin of 11.68% is fine compared to the rest of the industry. INVX outperforms 61.29% of its industry peers.
INVX's Operating Margin has improved in the last couple of years.
INVX has a better Gross Margin (34.30%) than 66.13% of its industry peers.
INVX's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 11.68%
PM (TTM) 15.61%
GM 34.3%
OM growth 3YN/A
OM growth 5Y64.81%
PM growth 3YN/A
PM growth 5Y120.24%
GM growth 3Y12.33%
GM growth 5Y4.04%
INVX Yearly Profit, Operating, Gross MarginsINVX Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40

8

2. Health

2.1 Basic Checks

INVX has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
Compared to 1 year ago, INVX has more shares outstanding
INVX has more shares outstanding than it did 5 years ago.
Compared to 1 year ago, INVX has a worse debt to assets ratio.
INVX Yearly Shares OutstandingINVX Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M
INVX Yearly Total Debt VS Total AssetsINVX Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B

2.2 Solvency

INVX has an Altman-Z score of 4.39. This indicates that INVX is financially healthy and has little risk of bankruptcy at the moment.
INVX's Altman-Z score of 4.39 is amongst the best of the industry. INVX outperforms 88.71% of its industry peers.
INVX has a debt to FCF ratio of 0.44. This is a very positive value and a sign of high solvency as it would only need 0.44 years to pay back of all of its debts.
INVX has a better Debt to FCF ratio (0.44) than 91.94% of its industry peers.
A Debt/Equity ratio of 0.03 indicates that INVX is not too dependend on debt financing.
Looking at the Debt to Equity ratio, with a value of 0.03, INVX belongs to the top of the industry, outperforming 88.71% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.03
Debt/FCF 0.44
Altman-Z 4.39
ROIC/WACC0.74
WACC9.3%
INVX Yearly LT Debt VS Equity VS FCFINVX Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M 1B

2.3 Liquidity

INVX has a Current Ratio of 3.94. This indicates that INVX is financially healthy and has no problem in meeting its short term obligations.
INVX's Current ratio of 3.94 is amongst the best of the industry. INVX outperforms 90.32% of its industry peers.
A Quick Ratio of 2.28 indicates that INVX has no problem at all paying its short term obligations.
INVX has a better Quick ratio (2.28) than 83.87% of its industry peers.
Industry RankSector Rank
Current Ratio 3.94
Quick Ratio 2.28
INVX Yearly Current Assets VS Current LiabilitesINVX Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

8

3. Growth

3.1 Past

INVX shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -126.67%.
Measured over the past years, INVX shows a very strong growth in Earnings Per Share. The EPS has been growing by 123.23% on average per year.
INVX shows a strong growth in Revenue. In the last year, the Revenue has grown by 81.84%.
INVX shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 9.76% yearly.
EPS 1Y (TTM)-126.67%
EPS 3YN/A
EPS 5Y123.23%
EPS Q2Q%775%
Revenue 1Y (TTM)81.84%
Revenue growth 3Y27.02%
Revenue growth 5Y9.76%
Sales Q2Q%98.42%

3.2 Future

The Earnings Per Share is expected to grow by 158.86% on average over the next years. This is a very strong growth
INVX is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 47.17% yearly.
EPS Next Y525.4%
EPS Next 2Y158.86%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year111.46%
Revenue Next 2Y47.17%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
INVX Yearly Revenue VS EstimatesINVX Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 200M 400M 600M 800M 1B
INVX Yearly EPS VS EstimatesINVX Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 0 2 4

5

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for INVX. In the last year negative earnings were reported.
INVX is valuated reasonably with a Price/Forward Earnings ratio of 11.00.
Compared to the rest of the industry, the Price/Forward Earnings ratio of INVX indicates a somewhat cheap valuation: INVX is cheaper than 69.35% of the companies listed in the same industry.
INVX is valuated rather cheaply when we compare the Price/Forward Earnings ratio to 21.08, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE N/A
Fwd PE 11
INVX Price Earnings VS Forward Price EarningsINVX Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 -20 -40

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, INVX is valued expensively inside the industry as 80.65% of the companies are valued cheaper.
INVX's Price/Free Cash Flow is on the same level as the industry average.
Industry RankSector Rank
P/FCF 13.82
EV/EBITDA 8.79
INVX Per share dataINVX EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 10

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
INVX has a very decent profitability rating, which may justify a higher PE ratio.
INVX's earnings are expected to grow with 158.86% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y158.86%
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

INVX does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

INNOVEX INTERNATIONAL INC

NYSE:INVX (4/17/2025, 8:04:01 PM)

After market: 15.91 0 (0%)

15.91

+0.64 (+4.19%)

Chartmill FA Rating
GICS SectorEnergy
GICS IndustryGroupEnergy
GICS IndustryEnergy Equipment & Services
Earnings (Last)02-25 2025-02-25/amc
Earnings (Next)N/A N/A
Inst Owners47.97%
Inst Owner Change0%
Ins Owners1.52%
Ins Owner Change2.9%
Market Cap1.10B
Analysts40
Price Target16.32 (2.58%)
Short Float %N/A
Short Ratio5.59
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend1.45
Dividend Growth(5Y)N/A
DP62.31%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-58.08%
Min EPS beat(2)-165.36%
Max EPS beat(2)49.19%
EPS beat(4)1
Avg EPS beat(4)-238.64%
Min EPS beat(4)-782.97%
Max EPS beat(4)49.19%
EPS beat(8)1
Avg EPS beat(8)-182.57%
EPS beat(12)3
Avg EPS beat(12)-86.51%
EPS beat(16)3
Avg EPS beat(16)-163.18%
Revenue beat(2)2
Avg Revenue beat(2)10.23%
Min Revenue beat(2)10.21%
Max Revenue beat(2)10.25%
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)6.67%
PT rev (3m)6.67%
EPS NQ rev (1m)0%
EPS NQ rev (3m)26.8%
EPS NY rev (1m)26.61%
EPS NY rev (3m)26.61%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)94.38%
Revenue NY rev (3m)94.38%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 11
P/S 1.43
P/FCF 13.82
P/OCF 11.81
P/B 1.15
P/tB 1.4
EV/EBITDA 8.79
EPS(TTM)-0.34
EYN/A
EPS(NY)1.45
Fwd EY9.09%
FCF(TTM)1.15
FCFY7.23%
OCF(TTM)1.35
OCFY8.47%
SpS11.12
BVpS13.81
TBVpS11.38
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 10.05%
ROE 12.56%
ROCE 8.7%
ROIC 6.88%
ROICexc 7.4%
ROICexgc 8.97%
OM 11.68%
PM (TTM) 15.61%
GM 34.3%
FCFM 10.35%
ROA(3y)3.87%
ROA(5y)-0.76%
ROE(3y)4.84%
ROE(5y)-0.55%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5Y74.94%
ROICexc growth 3YN/A
ROICexc growth 5Y70.29%
OM growth 3YN/A
OM growth 5Y64.81%
PM growth 3YN/A
PM growth 5Y120.24%
GM growth 3Y12.33%
GM growth 5Y4.04%
F-Score5
Asset Turnover0.64
Health
Industry RankSector Rank
Debt/Equity 0.03
Debt/FCF 0.44
Debt/EBITDA 0.21
Cap/Depr 43.56%
Cap/Sales 1.76%
Interest Coverage 45.24
Cash Conversion 77.05%
Profit Quality 66.35%
Current Ratio 3.94
Quick Ratio 2.28
Altman-Z 4.39
F-Score5
WACC9.3%
ROIC/WACC0.74
Cap/Depr(3y)71.76%
Cap/Depr(5y)56.98%
Cap/Sales(3y)4.99%
Cap/Sales(5y)4.26%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-126.67%
EPS 3YN/A
EPS 5Y123.23%
EPS Q2Q%775%
EPS Next Y525.4%
EPS Next 2Y158.86%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)81.84%
Revenue growth 3Y27.02%
Revenue growth 5Y9.76%
Sales Q2Q%98.42%
Revenue Next Year111.46%
Revenue Next 2Y47.17%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y3447.18%
EBIT growth 3YN/A
EBIT growth 5Y80.9%
EBIT Next Year-16.85%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y420.68%
FCF growth 3Y41.07%
FCF growth 5Y90.29%
OCF growth 1Y1109.25%
OCF growth 3Y34.47%
OCF growth 5Y44.76%